Muscle Oxygen Saturation and Functional Capacity in Breast Cancer Survivors

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age30-70
SponsorUniversity of Extremadura

About this trial

This cross-sectional observational study aims to assess muscle oxygen saturation (SmO2) in the intercostal, quadriceps, and triceps surae muscles using near-infrared spectroscopy (NIRS) during functional exercise tests in breast cancer survivors. Participants will be grouped based on their previous cancer treatment: hormonal therapy only or hormonal therapy combined with chemotherapy. Functional performance will be evaluated through the 6-Minute Walk Test, 30-Second Sit-to-Stand Test, and a submaximal treadmill test. The study will analyze differences in muscle oxygenation and performance between groups and explore associations with other functional and clinical parameters.

Eligibility criteria

Qualifiers

Women aged 30 to 70 years

Clinical history of breast cancer treatment (at least 6 months prior)

Completed primary cancer treatment

Ability to perform physical tests

Disqualifiers

Recurrence or metastasis

Severe cardiopulmonary or musculoskeletal disease

Neurological or cognitive limitations

Ongoing oncological treatment

Trial design

Treatments tested in this trial

  • Functional Exercise Testing and Muscle Oxygen Saturation Measurement

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators